| Literature DB >> 23527081 |
Ruyang Zhang1, Yang Zhao, Minjie Chu, Amar Mehta, Yongyue Wei, Yao Liu, Pengcheng Xun, Jianling Bai, Hao Yu, Li Su, Hongxi Zhang, Zhibin Hu, Hongbing Shen, Feng Chen, David C Christiani.
Abstract
BACKGROUND: Occupational exposure to endotoxin is associated with decrements in pulmonary function, but how much variation in this association is explained by genetic variants is not well understood.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23527081 PMCID: PMC3602449 DOI: 10.1371/journal.pone.0059035
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The mean and standard deviation of the rate of FEV1 decline (ES) in different subgroups.
| Subgroup | Mean ± SD (ml/month) of the rate of FEV1 decline ( | |||||
| Age | 18≤ Age | Age | ||||
| Height | ||||||
| Low | 0.65±24.53 | 30 | −12.00±45.37 | 40 | −8.47±14.65 | 44 |
| High | −1.73±23.47 | 43 | −2.95±23.68 | 67 | −12.67±9.08 | 77 |
| FEV1
| ||||||
| Low | −0.60±13.16 | 31 | −5.13±46.24 | 37 | −10.38±13.35 | 80 |
| High | −0.86±29.43 | 42 | −7.00±24.23 | 70 | −12.72±6.23 | 41 |
| Endotoxin | ||||||
| Low | −8.66±29.19 | 15 | −5.18±59.18 | 25 | −11.69±8.41 | 107 |
| High | 1.29±22.00 | 58 | −4.70±20.11 | 82 | −15.86±36.29 | 14 |
Subjects with age ≥ years were divided into two additional groups according median (25 years);
Subjects were divided into two groups according to median (160 cm, 2630 ml and 163 EU/m3 for height, FEV1 and endotoxin respectively);
Summary of results of the association study for top-10 SNPs using dominant model.
| SNP | Genotype |
| Mean± SD |
|
| Proportion |
|
| TT | 248 | −4.32±21.86 | −15.17(3.62) | 3.70×10−5 | 89.25% |
| TA+AA | 53 | −18.32±34.61 | ||||
|
| GG | 217 | −3.07±23.35 | −12.50(3.08) | 6.19×10−5 | 96.35% |
| GC+CC | 83 | −16.69±26.98 | ||||
| rs32588 | TT | 268 | −8.71±23.60 | 17.21(4.39) | 1.11×10−4 | 85.50% |
| TC+CC | 33 | 8.84±31.18 | ||||
| rs4855881 | AA | 257 | −9.08±22.28 | 14.83(3.92) | 1.84×10−4 | 83.35% |
| AG+GG | 44 | 6.60±34.96 | ||||
| rs10515978 | AA | 138 | −12.59±23.71 | 10.09(2.77) | 3.16×10−4 | 90.75% |
| AG+GG | 163 | −1.88±25.25 | ||||
| rs601675 | AA | 160 | −2.19±18.74 | −10.14(2.79) | 3.32×10−4 | 85.80% |
| AG+GG | 141 | −12.00±29.98 | ||||
| rs11761231 | AA | 167 | −11.54±21.07 | 10.05(2.77) | 3.35×10−4 | 89.60% |
| AG+GG | 134 | −0.86±28.32 | ||||
| rs10129426 | CC | 100 | −13.44±27.26 | 10.52(2.93) | 3.88×10−4 | 82.85% |
| CT+TT | 201 | −3.38±23.31 | ||||
| rs10201627 | GG | 241 | −4.23±23.05 | −12.35(3.47) | 4.41×10−4 | 85.45% |
| GT+TT | 60 | −17.05±30.10 | ||||
| rs1049970 | CC | 194 | −2.99±23.16 | −10.30(2.91) | 4.63×10−4 | 86.60% |
| CT+TT | 106 | −14.12±26.77 |
Mean and standard deviation of the rate of FEV1 decline (ml/month);
Coefficient, standard error and P value to SNP in linear regression model adjusted for height, age and FEV1 at baseline, and average log transformed endotoxin level;
Proportions of P value ≤0.005 in 2,000 bootstrap samples.
The results of gene-gene interaction analysis for top-10 SNPs (P<0.05).
| Gene1 | Gene2 |
| Mean± SD |
|
|
| FDR | ||
|
| rs1049970 | 4.18×10−2 | 0.0895 | ||||||
| TT | CC | 159 | −1.39±23.13 | Ref. | |||||
| TT | CT+TT | 88 | −10.05±17.89 | −7.69(3.09) | 1.35×10−2 | ||||
| TA+AA | CC | 35 | −10.25±22.17 | −9.79(4.36) | 2.56×10−2 | ||||
| TA+AA | CT+TT | 18 | −34.00±47.81 | −32.59(5.73) | 3.19×10−8 | ||||
| rs10515978 | rs32588 | 5.09×10−3 | 0.0313 | ||||||
| AA | TT | 123 | −13.12±24.95 | Ref. | |||||
| AA | TC+CC | 15 | −8.20±7.51 | 4.11(6.29) | 5.14×10−1 | ||||
| AG+GG | TT | 145 | −4.97±21.79 | 7.44(2.83) | 8.96×10−3 | ||||
| AG+GG | TC+CC | 18 | 23.04±36.25 | 35.68(5.83) | 2.96×10−9 | ||||
| rs11761231 | rs32588 | 5.16×10−3 | 0.0313 | ||||||
| AA | TT | 150 | −12.38±21.74 | Ref. | |||||
| AA | TC+CC | 17 | −4.13±11.92 | 5.01(5.96) | 4.02×10−1 | ||||
| AG+GG | TT | 118 | −4.04±25.10 | 7.01(2.85) | 1.43×10−2 | ||||
| AG+GG | TC+CC | 16 | 22.62±39.11 | 36.34(6.06) | 6.01×10−9 | ||||
| rs11761231 | rs4855881 | 9.51×10−3 | 0.0390 | ||||||
| AA | AA | 144 | −12.14±21.75 | Ref. | |||||
| AA | AG+GG | 23 | −7.80±16.14 | 5.15(5.22) | 3.25×10−1 | ||||
| AG+GG | AA | 113 | −5.18±22.45 | 6.90(2.90) | 1.81×10−2 | ||||
| AG+GG | AG+GG | 21 | 22.37±42.90 | 31.87(5.44) | 1.27×10−8 | ||||
rs1910047 (TBX3), rs1049970 (CDH5), rs10515978 (LMAN1), rs32588 (PPARGC1B) and rs4855881 (APEH);
Mean and stand deviation of the rate of FEV1 decline (ml/month);
Coefficient, stand error, P value were acquired from linear regression model adjusted for height, age and FEV1 at baseline, and average log transformed endotoxin level.
P value for gene-gene interaction.
FDR q-value calculated based on all pair-wise (45 pairs) P values of top-10 SNPs.
Figure 1The functional network based on four pairs of gene-gene interactions identified in this study.
Four gene-gene interaction functional paths were highlighted, including - VE_cadherin (), PERC () - , PERC () - Podocalyxin_like 1 () and Podocalyxin_like 1 () - .
The results of gene-environment interaction analysis for top-10 SNPs (P<0.05).
| Gene | Environment |
| Mean±SD |
|
|
| FDR |
|
| Age (years) | 0.0161 | 0.0264 | ||||
| GG | <18 | 53 | 3.16±25.29 | Ref. | |||
| GG | 18 ∼ 25 | 80 | 0.81±28.47 | −2.55(4.38) | 0.5607 | ||
| GG | >25 | 84 | −10.71±12.20 | −23.80(10.91) | 0.0300 | ||
| GC+CC | <18 | 20 | −11.10±15.35 | −13.23(6.17) | 0.0329 | ||
| GC+CC | 18 ∼ 25 | 26 | −22.69±40.84 | −25.84(5.85) | <0.0001 | ||
| GC+CC | >25 | 37 | −15.49±18.17 | −28.43(11.53) | 0.0143 | ||
| rs1049970 | Age (years) | 0.0206 | 0.0264 | ||||
| CC | <18 | 47 | 2.03±23.22 | Ref. | |||
| CC | 18 ∼ 25 | 78 | 0.78±28.14 | −2.63(4.55) | 0.5644 | ||
| CC | >25 | 69 | −10.67±12.94 | −22.43(11.30) | 0.0481 | ||
| CT+TT | <18 | 25 | −7.36±23.50 | −11.05(5.89) | 0.0618 | ||
| CT+TT | 18 ∼ 25 | 29 | −19.86±40.90 | −21.77(5.83) | 0.0002 | ||
| CT+TT | >25 | 52 | −14.17±16.02 | −25.78(11.20) | 0.0220 | ||
| rs10201627 | Age (years) | 0.0356 | 0.0308 | ||||
| GG | <18 | 60 | 0.62±25.41 | Ref. | |||
| GG | 18 ∼ 25 | 87 | 0.44±26.17 | −0.40(4.18) | 0.9247 | ||
| GG | >25 | 94 | −11.65±15.42 | −19.86(10.84) | 0.0679 | ||
| GT+TT | <18 | 13 | −7.09±12.84 | −9.39(7.23) | 0.1951 | ||
| GT+TT | 18 ∼ 25 | 20 | −27.66±48.70 | −28.07(6.25) | <0.0001 | ||
| GT+TT | >25 | 27 | −13.98±10.02 | −22.06(11.57) | 0.0576 | ||
| rs4855881 | Endotoxin (EU/m3) | 0.0454 | 0.4086 | ||||
| AA | <163 | 132 | −12.90±22.51 | Ref. | |||
| AA | ≥163 | 125 | −5.04±21.40 | 1.46(5.42) | 0.7876 | ||
| AG+GG | <163 | 15 | 12.82±45.55 | 27.98(6.51) | <0.0001 | ||
| AG+GG | ≥163 | 29 | 3.38±28.41 | 8.97(6.64) | 0.1777 |
rs9469089 (RNF5), rs1049970 (CDH5), rs10201627 (GPR55) and rs4855881 (APEH);
Mean and stand deviation of the rate of FEV1 decline (ml/month);
Coefficient, stand error, P value were acquired from linear regression model adjusted for height, age and FEV1 at baseline, and average log transformed endotoxin level.
P value for gene-environment interaction.
FDR q-value calculated based on top-10 SNPs (10 pairs for Age-SNP interactions and 10 pairs for SNP-Endotoxin interactions).
Figure 2The frequency distribution of genetic risk score (GRS) and the coefficient and 95% CI to genetic risk score in linear regression model adjusted for height, age and FEV1 at baseline, and average log transformed endotoxin level.
The more risk loci the subjects carried, the larger the rate of FEV1 decline occurred (P trend = 3.01×10−18).
Figure 3Stratification analysis of the associations between the rate of FEV1 decline and the genetic risk score (GRS) of top-10 SNPs.
Each box and horizontal line represents the Coefficient and 95% CI derived from the linear regression model adjusted for height, age and FEV1 at baseline, and average log transformed endotoxin level. P values of interaction between GRS and age/endotoxin were acquired from linear regression model with covariates adjustment.